Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer

NCT00242073 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00242073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00242073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer
Lead sponsor
University Health Network, Toronto
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2001
Completion date
August 31, 2008
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer